3,511 results found

This will allow Health Canada to consult broadly on the specific regulations addressing the unique risks posed by these kind products.

In November 2017, Health Canada published a consultation paper entitled Proposed Approach to the Regulation of Cannabis.

On July 11, 2018, after several months of consultations, the federal government published in the Canada Gazette the Cannabis Regulations, which holders of a licence issued by Health Canada ...

As COVID-19 cases surge, medical regulators are taking swift action to ensure that drugs required to treat the virus are prescribed based on evidence...

In January 2026, the Canadian Food Inspection Agency (“CFIA”) released the What we heard report: Consultation on proposed guidance on how to label and represent plant-based alternatives to egg products (the “Report”)...

As I write this article in early May 2020, I honestly do not know what the world will be like when you read this. However, I am confident that it will continue to be very ...

The Government of Canada published a Consultation Paper proposing regulatory changes to a class of products identified as "self-care products," namely cosmetics, natural health products and non-prescription drugs.

Last week, the Government of Canada signed an agreement to amend the United States-Mexico-Canada Agreement (USMCA).

The Rebate Order at issue states for means that the benefit is linked directly or indirectly to listed or interchangeable products sold or offered for sale to the pharmacy.

On November 12, 2019, the Canadian Securities Administrators (CSA) published Staff Notice 51-359 (the "Staff Notice"), highlighting inadequacies in disclosure of financial interests in M&A ...

Canada is subject to a patchwork of laws and policies relating to the pricing and reimbursement of drug products.

Following the recent legalization of recreational cannabis in Canada, now is a good time for Canadian employers to review their workplace policies to ensure ...

On December 3, 2020, the Federal Court of Appeal released its first decision providing guidance on the standard for obtaining leave to appeal interlocutory decisions under section 6.11(1) of the...

Rather, the Court's role is to determine whether the plaintiff raises an arguable case such that it is not plain and obvious the action will fail.

On May 26, 2023, the Minister of Health determined that Biosimilar Collaborations Ireland Limited was entitled to the benefit of section 5 of the Patented Medicines (Notice of Compliance) Regulations (Regulations)...

On November 10, 2021, the Minister of Health refused to reassess its decision that Janssen's esketamine hydrochloride product (SPRAVATO)...

If you're in the food business, for reasons of public health, trade and consumer protection, you're always swimming in a sea of regulations.